A week after pausing a leukemia trial due to the death of a patient, Magenta Therapeutics is halting development of all its programs and exploring a potential sale or other measures to wind down operations.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,